Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00226408
What this trial is testing

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Who this might be right for
AdjuvantStage III Malignant MelanomaInterferon Alpha+1 more
Dermatologic Cooperative Oncology Group 600
Testing effectiveness (Phase 2)UnknownNCT04226950
What this trial is testing

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

Who this might be right for
Essential Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 40
Post-approval studies (Phase 4)UnknownNCT02150291
What this trial is testing

A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin.

Who this might be right for
Hepatitis C
British University In Egypt 120
Testing effectiveness (Phase 2)Study completedNCT01935635
What this trial is testing

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 400
Testing effectiveness (Phase 2)UnknownNCT04793568
What this trial is testing

Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study

Who this might be right for
Critically Ill Patients
Nantes University Hospital 109
Testing effectiveness (Phase 2)Study completedNCT00115908
What this trial is testing

Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Human Genome Sciences Inc. 458
Testing effectiveness (Phase 2)Study completedNCT02309918
What this trial is testing

HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Acute Hepatitis C
HepNet Study House, German Liverfoundation 20
Not applicableStudy completedNCT03347370
What this trial is testing

A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 626
Large-scale testing (Phase 3)Study completedNCT00633542
What this trial is testing

Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)

Who this might be right for
Multiple Myeloma
Università Politecnica delle Marche 103
Large-scale testing (Phase 3)WithdrawnNCT01608737
What this trial is testing

A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Not applicableActive Not RecruitingNCT07204366
What this trial is testing

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

Who this might be right for
Myeloproliferative DiseaseCOVID - 19
Fondazione IRCCS Policlinico San Matteo di Pavia 219
Testing effectiveness (Phase 2)UnknownNCT00146913
What this trial is testing

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Who this might be right for
Chronic Myeloid Leukemia
Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT00249860
What this trial is testing

Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

Who this might be right for
Hepatitis C
EMD Serono 257
Large-scale testing (Phase 3)Study completedNCT00781274
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 32
Testing effectiveness (Phase 2)Study completedNCT00657189
What this trial is testing

Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus

Who this might be right for
Lupus Erythematosus, SystemicLupus
MedImmune LLC 87
Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing

Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT01935089
What this trial is testing

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

Who this might be right for
HIV-1 Infection
The Wistar Institute 20
Testing effectiveness (Phase 2)Study completedNCT00942591
What this trial is testing

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b

Who this might be right for
Multiple Sclerosis
Insel Gruppe AG, University Hospital Bern 77
Not applicableStudy completedNCT00705224
What this trial is testing

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus
Merck Sharp & Dohme LLC 250
Large-scale testing (Phase 3)Study completedNCT00780910
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 109
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation